Jane Street
IDNA icon

Jane Street’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Jane Street’s Portfolio IDNA Stock Details IDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-52,452
Closed -$1.37M – 12207
2025
Q4 		$1.37M Buy
52,452
+1,232
+2% +$31.7K ﹤0.01% 5505
2025
Q3 		$1.21M Buy
51,220
+7,149
+16% +$158K ﹤0.01% 5907
2025
Q2 		$904K Buy
+44,071
New +$888K ﹤0.01% 5804
2025
Q1 		– Sell
-29,257
Closed -$662K – 9941
2024
Q4 		$662K Buy
+29,257
New +$702K ﹤0.01% 6168
2024
Q3 		– Sell
-183,147
Closed -$4.23M – 9953
2024
Q2 		$4.23M Buy
183,147
+83,884
+85% +$1.96M ﹤0.01% 3230
2024
Q1 		$2.39M Sell
99,263
-386,996
-80% -$9.07M ﹤0.01% 3817
2023
Q4 		$11.2M Buy
486,259
+330,500
+212% +$6.64M ﹤0.01% 1827
2023
Q3 		$3.17M Buy
155,759
+103,871
+200% +$2.33M ﹤0.01% 3297
2023
Q2 		$1.21M Sell
51,888
-3,315
-6% -$79.5K ﹤0.01% 4910
2023
Q1 		$1.28M Sell
55,203
-29,172
-35% -$730K ﹤0.01% 4562
2022
Q4 		$2.12M Buy
84,375
+56,843
+206% +$1.53M ﹤0.01% 3780
2022
Q3 		$727K Sell
27,532
-76,885
-74% -$2.37M ﹤0.01% 5994
2022
Q2 		$3.02M Buy
104,417
+47,247
+83% +$1.41M ﹤0.01% 3431
2022
Q1 		$1.97M Sell
57,170
-91,990
-62% -$3.25M ﹤0.01% 4783
2021
Q4 		$6.54M Buy
149,160
+124,210
+498% +$5.88M ﹤0.01% 2448
2021
Q3 		$1.26M Sell
24,950
-16,164
-39% -$843K ﹤0.01% 5439
2021
Q2 		$2.14M Sell
41,114
-174,927
-81% -$8.21M ﹤0.01% 4204
2021
Q1 		$9.88M Buy
216,041
+182,225
+539% +$8.9M ﹤0.01% 1558
2020
Q4 		$1.55M Buy
+33,816
New +$1.46M ﹤0.01% 3956
2020
Q3 		– Sell
-30,721
Closed -$1.17M – 7487
2020
Q2 		$1.17M Buy
+30,721
New +$1.04M ﹤0.01% 3850
2019
Q3 		– Sell
-32,391
Closed -$880K – 5388
2019
Q2 		$880K Buy
+32,391
New +$852K ﹤0.01% 2863

Other funds holding IDNA

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
WBG
Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
PGA
Portland Global Advisors Portland, Maine $938M AUM 13.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
CCA
Clearwater Capital Advisors Hoffman Estates, Illinois $1.24B AUM 15.23% 1-Year Est. Return

Jane Street's IDNA Position: Q1 2026 in Review

Jane Street sold out of iShares Genomics Immunology and Healthcare ETF (IDNA) in Q1 2026, closing a stake of 52,452 shares — an estimated $1.37M sold.

Jane Street first reported a position in IDNA in Q2 2019 and held it in 21 quarters. The position peaked at $11.2M in Q4 2023. 60 funds tracked by Wall St. Rank hold IDNA as of Q1 2026.

  • Jane Street reported no remaining iShares Genomics Immunology and Healthcare ETF position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 52,452 iShares Genomics Immunology and Healthcare ETF shares in Q1 2026, an estimated $1.37M.
  • Jane Street first reported a position in iShares Genomics Immunology and Healthcare ETF in Q2 2019 and held it in 21 quarters.
  • Jane Street's iShares Genomics Immunology and Healthcare ETF position peaked at $11.2M in Q4 2023.
  • 60 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.